ZoomMed Inc. has sold certain assets to TELUS Health
July 2014 — TELUS Health, Canada’s largest Electronic Medical Records (EMR) provider and a leader in the Canadian claims and benefits management sector, is adding important new functionality to its existing health technology portfolio through its acquisition of an interest in the underlying technology of the ZRx Prescriber from Quebec-based ZoomMed Inc. Financial details have not been disclosed.
ZoomMed Inc. is a publicly traded company (TSXV: ZMD) that builds and operates a clinical information exchange platform between physicians, pharmacists and the various other stakeholders of the Health sector with whom they interact. The company has the largest private network of electronic prescriptions and drug information system in Canada.
TELUS Health is a leader in telehomecare, electronic medical and health records, consumer health, benefits management and pharmacy management. TELUS Health solutions give health authorities, providers, physicians, patients and consumers the power to turn information into better health outcomes. It is an operating subsidiary of TELUS (TSX: T), one of Canada’s largest telecommunication companies.
“This acquisition builds upon our EMR leadership position and claims and benefits expertise, and allows us to have a more direct and positive impact on the patient experience, which ultimately leads to better health outcomes for Canadians,” said Paul Lepage, President of TELUS Health.
Our role in the transaction
Oaklins' team in Montreal advised the seller in this transaction.
Contacter l'équipe de la transaction
Transactions connexes
Life & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
En apprendre plusAsana Gruppe has sold selected outpatient service areas to Luzerner Kantonsspital
Luzerner Kantonsspital (LUKS) has acquired key parts of Asana Spital Menziken AG’s outpatient services from Asana Gruppe AG, including its ambulance service, primary care practice and ambulatory care center. The transaction supports the long-term continuity of local medical care in the Swiss Wynen and Seetal regions and ensures these services remain available close to patients’ homes.
En apprendre plusLaboratoires Herbolistique has received a majority investment from Yotta Capital Partners and co-investors
Laboratoires Herbolistique has received a majority investment from Yotta Capital Partners alongside co-investors Ouest Croissance, Sodero and CE IDF, with Bpifrance, Océans Participations and the management team reinvesting.
En apprendre plus